Pomanda estimates the enterprise value of ABBOTT VASCULAR DEVICES (2) LIMITED at £0 based on a Turnover of £0 and 1.26x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ABBOTT VASCULAR DEVICES (2) LIMITED at £0 based on an EBITDA of £-7k and a 5.31x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ABBOTT VASCULAR DEVICES (2) LIMITED at £0 based on Net Assets of £-823k and 1.78x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abbott Vascular Devices (2) LimitedOverview
Abbott Vascular Devices (2) Limited is a live company located in maidenhead, SL6 4XE with a Companies House number of 04304983. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in October 2001, it's largest shareholder is
abbott vascular devices ltd
with a 100% stake. Abbott Vascular Devices (2) Limited is a mature,
unknown sized company, Pomanda has estimated its turnover at
£0 with
declining
growth in recent years.
There is insufficient data available to calculate a health check for Abbott Vascular Devices (2) Limited. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (5.2%)
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (111)
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Abbott Vascular Devices (2) Limited
- - Industry AVG
ABBOTT VASCULAR DEVICES (2) LIMITED financials
EXPORT
Abbott Vascular Devices (2) Limited's latest turnover from December 2023 is 0 and the company has net assets of -£823 thousand. According to their latest financial statements, we estimate that Abbott Vascular Devices (2) Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Turnover
8,000
54,000
139,000
570,000
180,000
390,000
471,000
2,495,000
5,888,000
8,535,000
8,641,000
Other Income Or Grants
Cost Of Sales
4,000
27,000
114,000
463,000
1,001,000
952,000
936,000
1,195,000
3,308,000
75,000
87,000
Gross Profit
4,000
27,000
25,000
107,000
-821,000
-562,000
-465,000
1,300,000
2,580,000
8,460,000
8,554,000
Admin Expenses
7,000
6,000
10,000
6,000
6,000
9,000
2,488,000
31,000
16,000
8,000
51,000
23,000
5,720,000
5,632,000
Operating Profit
-7,000
-6,000
-10,000
-2,000
-6,000
18,000
25,000
-2,381,000
-852,000
-578,000
-473,000
1,249,000
2,557,000
2,740,000
2,922,000
Interest Payable
38,000
12,000
1,000
2,000
8,000
11,000
1,000
Interest Receivable
2,000
3,000
3,000
8,000
13,000
13,000
9,000
5,000
17,000
11,000
Pre-Tax Profit
-45,000
-18,000
-11,000
-4,000
-14,000
9,000
28,000
-2,378,000
-844,000
-565,000
-460,000
1,258,000
2,562,000
2,757,000
2,932,000
Tax
-3,000
87,000
-74,000
-372,000
Profit After Tax
-45,000
-18,000
-11,000
-4,000
-14,000
9,000
28,000
-2,381,000
-844,000
-478,000
-460,000
1,184,000
2,190,000
2,757,000
2,932,000
Dividends Paid
1,418,000
Retained Profit
-45,000
-18,000
-11,000
-4,000
-14,000
9,000
28,000
-2,381,000
-844,000
-478,000
-460,000
1,184,000
772,000
2,757,000
2,932,000
Employee Costs
Number Of Employees
1
1
1
1
1
1
1
3
3
3
3
12
4
3
3
EBITDA*
-7,000
-6,000
-10,000
-2,000
-6,000
18,000
25,000
-2,381,000
-852,000
-578,000
-473,000
1,249,000
2,557,000
2,740,000
2,922,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
510,000
Total Fixed Assets
510,000
Stock & work in progress
Trade Debtors
1,818,000
2,584,000
19,000
222,000
639,000
818,000
2,883,000
Group Debtors
304,000
304,000
304,000
1,230,000
3,201,000
2,757,000
1,024,000
413,000
2,260,000
Misc Debtors
1,000
487,000
6,000
49,000
49,000
65,000
53,000
146,000
394,000
1,614,000
Cash
26,000
21,000
25,000
223,000
500,000
174,000
232,000
171,000
669,000
1,604,000
1,217,000
53,000
misc current assets
total current assets
1,000
26,000
325,000
329,000
1,014,000
1,736,000
2,041,000
2,865,000
3,456,000
3,701,000
3,413,000
2,842,000
6,810,000
total assets
1,000
26,000
325,000
329,000
1,014,000
1,736,000
2,041,000
2,865,000
3,456,000
3,701,000
3,413,000
2,842,000
7,320,000
Bank overdraft
Bank loan
Trade Creditors
2,500,000
422,000
401,000
506,000
289,000
1,105,000
1,398,000
1,517,000
Group/Directors Accounts
816,000
773,000
752,000
767,000
1,060,000
1,048,000
1,751,000
6,000
3,000
7,112,000
other short term finances
hp & lease commitments
other current liabilities
7,000
6,000
8,000
8,000
10,000
12,000
3,000
4,000
6,000
7,000
27,000
23,000
106,000
17,000
21,000
total current liabilities
823,000
779,000
760,000
775,000
1,070,000
1,060,000
1,754,000
2,504,000
428,000
408,000
533,000
318,000
1,214,000
1,415,000
8,650,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
823,000
779,000
760,000
775,000
1,070,000
1,060,000
1,754,000
2,504,000
428,000
408,000
533,000
318,000
1,214,000
1,415,000
8,650,000
net assets
-823,000
-778,000
-760,000
-749,000
-745,000
-731,000
-740,000
-768,000
1,613,000
2,457,000
2,923,000
3,383,000
2,199,000
1,427,000
-1,330,000
total shareholders funds
-823,000
-778,000
-760,000
-749,000
-745,000
-731,000
-740,000
-768,000
1,613,000
2,457,000
2,923,000
3,383,000
2,199,000
1,427,000
-1,330,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Operating Activities
Operating Profit
-7,000
-6,000
-10,000
-2,000
-6,000
18,000
25,000
-2,381,000
-852,000
-578,000
-473,000
1,249,000
2,557,000
2,740,000
2,922,000
Depreciation
Amortisation
Tax
-3,000
87,000
-74,000
-372,000
Stock
Debtors
-1,000
1,000
-304,000
-487,000
-445,000
-631,000
-766,000
-652,000
253,000
1,223,000
184,000
-5,642,000
7,267,000
Creditors
-2,500,000
2,078,000
21,000
-105,000
217,000
-816,000
-293,000
-119,000
1,517,000
Accruals and Deferred Income
1,000
-2,000
-2,000
-2,000
9,000
-1,000
-2,000
-1,000
-20,000
4,000
-83,000
89,000
-4,000
21,000
Deferred Taxes & Provisions
Cash flow from operations
-5,000
-9,000
-10,000
300,000
-8,000
514,000
-2,031,000
323,000
-66,000
36,000
-505,000
-947,000
1,797,000
8,259,000
-2,807,000
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
43,000
21,000
-15,000
-293,000
12,000
-703,000
1,751,000
-6,000
3,000
3,000
-7,112,000
7,112,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
12,000
-4,262,000
interest
-38,000
-12,000
-1,000
-2,000
-8,000
-9,000
3,000
3,000
8,000
13,000
13,000
9,000
5,000
17,000
10,000
cash flow from financing
5,000
9,000
-16,000
-295,000
4,000
-712,000
1,754,000
3,000
8,000
25,000
7,000
12,000
8,000
-7,095,000
2,860,000
cash and cash equivalents
cash
-26,000
5,000
-4,000
-198,000
-277,000
326,000
-58,000
61,000
-498,000
-935,000
387,000
1,164,000
53,000
overdraft
change in cash
-26,000
5,000
-4,000
-198,000
-277,000
326,000
-58,000
61,000
-498,000
-935,000
387,000
1,164,000
53,000
abbott vascular devices (2) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for abbott vascular devices (2) limited. Get real-time insights into abbott vascular devices (2) limited's credit score, group structure and payment trends.
Perform a competitor analysis for abbott vascular devices (2) limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in SL6 area or any other competitors across 12 key performance metrics.
abbott vascular devices (2) limited Ownership
ABBOTT VASCULAR DEVICES (2) LIMITED group structure
Abbott Vascular Devices (2) Limited has no subsidiary companies.
The sole shareholder of Abbott Vascular Devices (2) Limited is Abbott Vascular Devices Ltd.
abbott vascular devices ltd
100%
abbott vascular devices (2) limited directors
Abbott Vascular Devices (2) Limited currently has 7 directors.
The longest serving directors include
Ms Camilla Soenderby (Jan 2010) and
Mr Neil Harris (Aug 2018).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to abbott vascular devices (2) limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ABBOTT VASCULAR DEVICES (2) LIMITED. This can take several minutes, an email will notify you when this has completed.
abbott vascular devices (2) limitedCompanies House Filings - See Documents
